BSETrident Texofab LtdLowNeutral
Announced Mon, 1 Sept · 16:22 IST

Annual Report for FY 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab has submitted the Notice of its 17th Annual General Meeting along with the Annual Report for FY 2024-25 to BSE. The AGM will be held on September 25, 2025 at 4:00 PM IST via video conferencing, with the cut-off date for e-voting eligibility set as September 18, 2025. For FY25, the company reported a 23% increase in revenue from operations to ₹12,205.62 lakhs (from ₹9,948.34 lakhs in FY24), while profit after tax more than doubled to ₹251.01 lakhs (from ₹107.98 lakhs). Q4 FY25 recorded a strong all-time-high revenue of ₹3,820.63 lakhs, up 27% year-on-year. Manufacturing now contributes 66% of revenue, compared with 0% in FY18, reflecting the company's strategic transformation from a pure trading entity to a manufacturing-led textile enterprise with ~250 lakh metres of annual production capacity.

Likely market impact

This is a routine regulatory filing providing shareholders access to the company's full annual report ahead of the AGM. The improved revenue and profitability metrics suggest the manufacturing-led business model is delivering results, though operating profit margins contracted to 4.5% from 6.2%, which shareholders may want to examine more closely in the detailed financials.